The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
Abstract
Background The intercellular adhesion molecule ICAM-1 mediates adhesion and transmigration of leucocytes to the vascular endothelial wall, a step proposed to be critical in the initiation and progression of atherosclerosis. Whether concentrations of soluble ICAM-1 (sICAM-1) are raised in apparently healthy individuals who later suffer acute myocardial infarction is unknown.Methods We obtained baseline plasma samples from a prospective cohort of 14,916 healthy men enrolled in the Physicians' Health Study. With a nested case-control design, we measured sICAM-1 concentrations for 474 participants who developed a first myocardial infarction, and 474 controls (participants who remained healthy throughout the 9-year follow-up). Cases were matched to controls according to age and smoking status at the time of myocardial infarction.Findings We found a significant association between increasing concentration of sICAM-1 and risk of future myocardial infarction (p = 0.003), especially among participants with baseline sICAM-1 concentrations in the highest quartile (> 260 ng/mL; relative risk 1.6 [95% Cl 1.1-2.4], p = 0.02). This association was present overall as well as among non-smokers, and persisted after control for lipid and non-lipid risk factors. In multivariate analyses, the risk of future myocardial infarction was 80% higher for participants with baseline sICAM-1 concentrations in the highest quartile (relative risk 1.8 [1.1-2.8], p = 0.02). Similar risk estimates were seen among non-smokers. We found slight but significant correlations between sICAM-1 and fibrinogen, high-density-lipoprotein cholesterol, homocysteine, triglycerides, tissue-type plasminogen-activator antigen, and C-relative protein, but adjustment for these altered the risk little. The risk of myocardial infarction associated with raised concentrations of sICAM-1 seemed to increase with length of follow-up.Interpretation Our data support the hypothesis that cellular mediators of inflammation have a role in atherogenesis and provide a clinical basis to consider antiadhesion therapies as a novel means of cardiovascular disease prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“sICAM-1 has been shown to be associated with increased risk of future nonfatal cardiovascular events and incident diabetes. 37,38”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [37]
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,710
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
Davies, M. J., Gordon, J. L., Gearing, A. J. H., Pigott, R., Woolf, N., Katz, D. R., & Kyriakopoulos, A. (1993) · The Journal of Pathology · doi:10.1002/path.1711710311 · Cited by 777
Pigott, R., Dillon, L. P., Hemingway, I., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 650
Cited by
Sorted by citations
Items 901–999 of 999
Insulin Treatment in Type 2 Diabetes
Ryysy, L. (2001) · Työväentutkimus Vuosikirja · Cited by 9
Polychlorinated biphenyls, oxidative stress, and diet
Hennig, B., Toborek, M. J., Ramadass, P., Ludewig, G., & Robertson, L. W. (2005) · doi:10.1201/9781420037531-4 · Cited by 9
Cell adhesion molecules in cardiovascular disease: what can soluble levels tell us?
Blann, A. D., & Lip, G. Y. H. (1999) · Heart · doi:10.1136/hrt.81.1.101 · Cited by 9
Opincariu, D., Rodean, I. P., Raț, N., Hodaş, R., Benedek, I., & Benedek, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153435 · Cited by 9
Masheto, G. R., Moyo, S. M., Mohammed, T., Banda, C., Raphaka, C., Mayondi, G. K., Makhema, J. M., Shapiro, R., Mosepele, M., Zash, R., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281910 · Cited by 8
“Unlike prior data from non-pregnant adults [23,26], we found that median ICAM1 levels were higher in women without HIV compared with WLHIV.”
ResultLee, Y. J., Han, B. H., Yoon, J. J., Kim, H. Y., Ahn, Y. M., Hong, M. H., Son, C. O., Kang, D. G., & Lee, H. S. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153430 · Cited by 8
Soluble integrin adhesion receptors and atherosclerosis: much heat and a little light?
Hillis, G. S. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001569 · Cited by 8
Lazzarin, N., Desideri, G., Ferri, C., Valensise, H. C. C., Gagliardi, G., Tiralongo, G. M., & Manfellotto, D. (2012) · Pregnancy Hypertension · doi:10.1016/j.preghy.2012.02.002 · Cited by 8
Adhesion molecules and C-reactive protein are associated to adverse events in angina pectoris
Eschen, O., Christensen, J. H., Johnsen, S. P., Dethlefsen, C., & Schmidt, E. B. (2010) · Scandinavian Cardiovascular Journal · doi:10.3109/14017431003615634 · Cited by 8
“6 (18), whereas another study from the Physicians health study reported no predictive value of sVCAM-1 for future risk of IHD (19).”
BackgroundContaminación atmosférica y daño cardiovascular
Oscar Román, A., Prieto, M. J., & Mancilla, P. (2004) · Revista médica de Chile · doi:10.4067/s0034-98872004000600014 · Cited by 8
Sini, S. (2013) · International Journal of Nutrition and Food Sciences · doi:10.11648/j.ijnfs.20130203.11 · Cited by 8
“Cellular adhesion molecules (CAMs) and matrix metalloproteinases (MMPs) have also been suggested to represent an important factor in atheromatous plaque disruption and the occurrence of acute coronary syndromes[20].”
BackgroundEndothelial function and the prediction of CVD in diabetes
Bugiardini, R. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0046-3 · Cited by 8
Afzalpour, M. E., Nayebifar, S., Kazemi, T., Abtahi‐Eivary, S., & Mogharnasi, M. (2016) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2016.60712 · Cited by 8
“The use of ICAM-1as a biomarker of endothelial dysfunction that can independently predict cardiovascular diseases (CVD) has been documented previously (Ridker et al., 1998).”
Gerinnung und Fibrinolyse bei Arteriosklerose
Hoffmeister, H. M., Heller, W., & Seipel, L. (1999) · Zeitschrift für Kardiologie · doi:10.1007/s003920050292 · Cited by 8
“Für eine sICAM-Erhöhung wurde ein Zusammenhang mit dem Auftreten eines akuten Myokardinfarktes im längerfristigen Verlauf bei initial Gesunden gefunden (79).”
BackgroundMarkers of Cardiac Ischemia and Inflammation
Wang, T. Y., AlJaroudi, W., & Newby, L. K. (2005) · Cardiology Clinics · doi:10.1016/j.ccl.2005.08.007 · Cited by 8
Effects of diet and of dietary components on endothelial leukocyte adhesion molecules
Caterina, R. D., & Massaro, M. (1999) · Current Atherosclerosis Reports · doi:10.1007/s11883-999-0031-9 · Cited by 8
Perez, R. V. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.10.1113 · Cited by 8
Ohara, H., Ito, S., & Takanami, Y. (2023) · BMC Public Health · doi:10.1186/s12889-023-15511-3 · Cited by 8
Dettmer, M., Alekel, D. L., Lasrado, J. A., Messina, M. J., Carriquiry, A., Heiberger, K., Stewart, J. W., & Franke, W. D. (2012) · Journal of the American College of Nutrition · doi:10.1080/07315724.2012.10720015 · Cited by 7
“Unlike sVCAM-1, sICAM-1 has been found to be an independent risk factor for myocardial infarction (Hwang et al 1997; Ridker et al. 1998) and has consistently been associated with established CVD risk factors in males (Demerath et al.”
BackgroundGenetic markers: Potential candidates for cardiovascular disease
Rather, R. A., & Dhawan, V. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.251 · Cited by 8
Kubysheva, N. I., POSTNIKOVA, L. B., Келдибековна, С. С., Vv, N., Shumilova, S. V., Kasatova, E. S., Eliseeva, T. I., Игнатов, С. К., Li, T. V., & Batyrshin, I. (2017) · Современные технологии в медицине · doi:10.17691/stm2017.9.2.13 · Cited by 7
A systematic review and meta-analysis of the effect of statin treatment on sVCAM-1 and sICAM-1
Zinellu, A., & Mangoni, A. A. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2072294 · Cited by 7
Hwang, Y.-S., Tsai, W., Lu, Y., Lin, C.-C., & Tsai, K.-Y. (2005) · Current Therapeutic Research · doi:10.1016/j.curtheres.2005.06.005 · Cited by 7
Metabolic Predictors of Inflammation, Adhesion, and Coagulability in Healthy Younger‐aged Adults
Mills, P. J., Shapiro, D., Goldstein, I. B., Ottaviani, C., Pung, M. A., Khandrika, S., von Känel, R., & Rutledge, T. R. (2008) · Obesity · doi:10.1038/oby.2008.420 · Cited by 7
“In sum, determining the circulating levels of these inflammatory biomarkers can provide insight into the pathophysiology of and risk for future events of several cardiovascular diseases (4,7).”
BackgroundStocco, B., Fumagalli, H. F., Franceschini, S. A., Martínez, E. Z., Marzocchi-Machado, C. M., & Tolói, M. R. T. (2012) · Contraception · doi:10.1016/j.contraception.2012.03.013 · Cited by 7
“The levels of these adhesion molecules present in the serum and in the plasma are considered markers for atherosclerosis and cardiovascular disease [5,6].”
BackgroundMarkers of Preclinical Atherosclerosis and their Clinical Relevance
Poredoš, P. (2011) · The Open Atherosclerosis & Thrombosis Journal · doi:10.2174/1876506801104010001 · Cited by 7
Khaleghi, M., Ali, Z., Mosley, T. H., Turner, S. T., & Kullo, I. J. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.107003 · Cited by 7
“... progression of atherosclerotic lesions (3, 4). Previous studieshaveshownincreasedexpressionofcellularadhesion molecules in several components of atherosclerotic plaque(5, 6). Circulating concentrations of soluble adhesion molecules such as soluble intercellular adhesion molecule 1 (sICAM-1)4 and soluble vascular c…”
Backgroundvon Känel, R., Preckel, D., Kudielka, B. M., & Fischer, J. E. (2007) · Physiological Research · doi:10.33549/physiolres.931037 · Cited by 7
“In apparently healthy men, sICAM-1 increased the prospective risk of developing first time myocardial infarction (Ridker et al. 1998) and peripheral arterial disease (Pradhan et al. 2002).”
BackgroundInflammatory markers: linking unstable plaques to coronary event, an interventional perspective
Aronson, D. (2004) · International Journal of Cardiovascular Interventions · doi:10.1080/14628840410030522 · Cited by 7
Association between NF-κB Pathway Gene Variants and sICAM1 Levels in Taiwanese
Wu, S., Teng, M., Er, L., Hsiao, W., Hsu, L., Yeh, C., Lin, J.-F., Lin, Y., Su, C.-W., & Ko, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169516 · Cited by 7
Pathophysiology of Atherosclerosis
Fernando, S., Bursill, C. A., Nicholls, S. J., & Psaltis, P. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-43683-4_2 · Cited by 7
Huang, W., Li, S., Luo, N., Lu, K., Ban, S., & Lin, H. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1073-2346 · Cited by 7
“The vascular compliance injury can inhibit the activity of endothelial nitric oxide synthase (eNOS) then reduce the release of nitric oxide (NO) [18].”
BackgroundNewer risk markers and surrogate endpoints in atherosclerosis management
Ballantyne, C. M. (2009) · Clinical Cardiology · doi:10.1002/clc.4960241504 · Cited by 7
Rheumatoid disease and ischaemic heart disease: Insights from pathophysiology and vascular biology
Bhatia, G. S., Sosin, M. D., Khattak, F., Davis, R., & Lip, G. Y. H. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.12.064 · Cited by 7
Schulze, P. C., Kluge, E., Schuler, G. C., & Lauer, B. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvb.22.12.2105-a · Cited by 7
Bhandari, S., Kyrrestad, I., Simón-Santamaría, J., Li, R., Szafranska, K. J., Dumitriu, G., Sánchez Romano, J., Smedsrød, B., & Sørensen, K. K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1377136 · Cited by 6
Heuberger, J. A. A. C., Posthuma, J. J., Ziagkos, D., Rotmans, J. I., Daniels, J. M. A., Gal, P., Stuurman, F. E., Spronk, H. M. H., Cate, H. T., Burggraaf, J., et al. (2020) · European Journal of Applied Physiology · doi:10.1007/s00421-020-04419-0 · Cited by 6
Chang, C. M., Thakur, S., de Oca, R. M., Rostron, B. L., Cheng, Y.-C., Wright, M. J., van Bemmel, D. M., Wang, L., & Hatsukami, D. K. (2024) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-1471 · Cited by 6
Evans, W. S., Pena, G. S., Gelman, B., Kuzmiak‐Glancy, S., & Prior, S. J. (2024) · Experimental Physiology · doi:10.1113/ep091901 · Cited by 6
“…concentrations of pro-inflammatory cytokines such as IL-6, IL-1 β , TNF α , CRP and MCP-1 are elevated in chronic CVDs and are correlated with poor CVD outcomes (Hoogeveen et al., 2005; Ridker et al., 1997, 1998, 2001, 2002, 2017; Pfeffer, et al., 2000; Ridker, Rifai, Stampfer, et al., 2000).”
BackgroundThe Role of Unknown Risk Factors in Myocardial Infarction
Ali, R. A. (2010) · Cardiology Research · doi:10.4021/cr103e · Cited by 6
“Fortunately, inflammatory markers are measurable and main markers including hsCRP, IL-6, P-selective sVCAM, CD40, and leukocyte activator agents such as Myeloperoxidase (MPO) could be measured exactly in laboratories [16-19].”
BackgroundEstrogen, progesterone, and cardiovascular health: when shall we complete the puzzle?
Brzezinski, A., & Danenberg, H. D. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000177320.31629.df · Cited by 6
Zemlin, A. E., Matsha, T. E., Kengne, A. P., Hon, G. M., & Erasmus, R. T. (2016) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563216640001 · Cited by 6
“Soluble forms of cellular adhesion molecules can be found in plasma, and it has been suggested that elevated plasma concentrations of some cellular adhesion molecules may be an index of endothelial activation(7) or even a molecular marker of early atherosclerosis.(4,25) The purpose of this study was to examine the rel…”
BackgroundSuarez, E. C. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195394399.013.0010 · Cited by 6
Evangelista, V., Dell’Elba, G., Celardo, A., Manarini, S., & Cerletti, C. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00067.x · Cited by 6
Hlivák, P., Jahnova, E., Odraska, J., Ferencĭk, M., Ebringer, L., & Mikeś, Z. (2005) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656719 · Cited by 6
Decrease in sE-Selectin after Pituitary Surgery in Patients with Acromegaly
Schmid, C., Wiesli, P., Bernays, R. L., Bloch, K. E., Zapf, J., Zwimpfer, C., Ghirlanda-Keller, C., & Brändle, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.028779 · Cited by 6
Seccia, T. M., & Rossi, G. P. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500295600 · Cited by 6
Interleukin 18 and sICAM-1 serum levels in families with type 1 diabetes mellitus.
Mirończuk, K., Okruszko, A., Wawrusiewicz‐Kurylonek, N., Kretowski, A. J., Kinalska, I., & Górska, M. (2005) · PubMed · Cited by 6
Markers of endothelial cell activation in elderly men at high risk for coronary heart disease
Hjerkinn, E. M., Seljeflot, I., Sandvik, L., Hjermann, I., & Arnesen, H. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510510013613 · Cited by 6
“In the Physicians’ Health Study, levels of sICAM-1 were elevated in subjects who later developed myocardial infarction (MI) compared with those who did not [7].”
BackgroundEarly use of statins in acute coronary syndromes
Spin, J. M., & Vagelos, R. H. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0064-y · Cited by 6
Randomised trials of new surgical procedures are necessary
Sharples, L. D., Caine, N., Schofield, P. M., Shapiro, L. M., DUNNING, J., & Wallwork, J. L. (1999) · Heart · doi:10.1136/hrt.81.1.100 · Cited by 6
Coronary heart disease: pathophysiological events and risk factors
Ferns, G. A., & Lamb, D. J. (2001) · Nutrition Bulletin · doi:10.1046/j.1467-3010.2001.00163.x · Cited by 7
Control of leukocyte adhesion and activation in atherogenesis
Berliner, J. A., Vora, D. K., & Shih, P. T. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8743-4_13 · Cited by 6
Wilson, M., Hamid, A. A., Abbas, I. I., Birkett, J. W., Khan, I., Harper, M., Al‐Jumeily, D., & Assi, S. A. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15593 · Cited by 7
Shirpoor, A., Ansari, M. H. K., Heshmatian, B., Ilkhanizadeh, B., Noruzi, L., Abdollahzadeh, N., & Saboory, E. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00184.x · Cited by 5
“ICAM-1 enables the adhesion and transmigration of inflammatory cells to the vascular wall.(32) The soluble forms of these molecules in plasma can be considered as a marker of atherogenesis and endothelial dysfunction.”
BackgroundEarly markers of endothelial dysfunction posttraumatic stress disorder. Role in atherogenesis
Azcurra, D. S. (2010) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/s2173-5050(10)70022-4 · Cited by 5
Azcurra, D. S. (2010) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2010.09.004 · Cited by 5
Madjid, M., Casscells, S. W., & Willerson, J. T. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_28 · Cited by 5
Chen, X., Lu, Y., Fan, Y., & Shen, Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100999-4.00005-8 · Cited by 5
Caballero‐Marcos, A., Romero‐Cristóbal, M., Puerto, M., Fernández‐Yunquera, A., Dieguez, L., Navarrete, C., Clemente, A. P. G., Díaz‐Fontenla, F., Catalán, P., Rincón, D., et al. (2021) · Transplant International · doi:10.1111/tri.14000 · Cited by 5
“Increased levels of intracellular adhesion molecules have been associated with atherosclerotic disease and an adverse cardiovascular prognosis [17,18].”
BackgroundBaba, M. S., Laway, B. A., Misgar, R. A., Wani, A. I., Bashir, M. I., Bhat, I. A., Haq, M. G., & Shah, Z. A. (2023) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_201_22 · Cited by 5
Nukala, S. B., Baron, G., Aldini, G., Carini, M., & D’Amato, A. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00593 · Cited by 5
Human Studies of Antioxidants and Vascular Function
Biegelsen, E. S., & Vita, J. A. (2000) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-4649-8_12 · Cited by 6
Ishikawa, M., Namiki, A., Kubota, T., Fukazawa, M., Joki, N., Moroi, M., Suzuki, M., Hase, H., & Yamaguchi, T. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02064-1 · Cited by 5
Marcadores inflamatórios intracoronarianos após intervenções coronarianas percutâneas
Filho, W. S., Filho, E. E. M., Horta, P. E., Lemos, P. A., Migueletto, B. C., Junior, C. V. S., Ramires, J. A. F., & Martinez, T. L. D. R. (2005) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2005001600006 · Cited by 5
Intermittent claudication and endothelial dysfunction
Silvestro, A. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90015-5 · Cited by 5
le Poole, C. Y., Schalkwijk, C. G., Teerlink, T., Valentijn, R. M., ter Wee, P. M., & van Ittersum, F. J. (2013) · Peritoneal Dialysis International · doi:10.3747/pdi.2012.00097 · Cited by 5
“nonrenal patient groups, high levels of hsCRP and markers of endothelial activation were associated with a significantly higher risk for cardiovascular morbidity and mortality (10,11).”
BackgroundICAM-1: Contribution to Vascular Inflammation and Early Atherosclerosis
Sabine, I., & Lawso, C. (2012) · InTech eBooks · doi:10.5772/29608 · Cited by 6
Time course of plasma adhesion molecules in acute coronary syndromes
Hope, S. A., Meredith, I. T., Farouque, H. M. O., Worthley, S. G., Plunkett, J. C., & Balazs, N. D. H. (2002) · Coronary Artery Disease · doi:10.1097/00019501-200206000-00003 · Cited by 5
Wagner, E.-Y. N., Hong, S., Wilson, K. L., Calfas, K. J., Rock, C. L., Redwine, L. S., von Känel, R., & Mills, P. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030655 · Cited by 5
“The reason for that is mainly seen in endothelial activation [12], which explains the tight linkage between elevated BP, chronic inflammatory processes including atherosclerosis and adverse health related outcomes [7,16].”
BackgroundSoluble adhesion molecules and coronary heart disease
Ballantyne, C. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07644-4 · Cited by 5
Binkley, P. F., Cooke, G. E., Lesinski, A., Taylor, M. B., Chen, M., Laskowski, B. F., Waldman, W. J., Ariza, M. E., Williams, M. V., Knight, D. A., et al. (2013) · PLoS ONE · doi:10.1371/annotation/834e21b0-6acb-40ae-8735-f7ad120c989a · Cited by 5
Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide
Sattar, N., Linetzky, B., Ruotolo, G., Verma, S., Sourij, H., Wang, H., Vanderman, K., Wilson, J. M., Griffin, R. M., Stefanski, A., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.04.044 · Cited by 5
Honarm, H., Mirzajani, E., Rahbar Taromsari, M., Saadat, F., Mirblock, F., & Mashayekhi, F. (2011) · African Journal of Microbiology Research · doi:10.5897/ajmr11.244 · Cited by 4
“…in serum is normal, other indicators such as serum amyloid A, ICAM1, VCAM-1, homocystein, preinflamatory cytokins such as IL-1 and Il-6, and acute phase proteins especially CRP can be regarded as indicators for MI (Hwang et al., 1997; Ridker et al., 1997; 2000; 1998; 1999; Harris et al., 1999).”
BackgroundShirani, M., Talebi, S., Sadeghi, O., Hassanizadeh, S., Askari, G., Bagherniya, M., & Sahebkar, A. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106963 · Cited by 4
Grinberg, T., Eisen, A., Talmor‐Barkan, Y., Kornowski, R., Hamdan, A., Witberg, G., Ayers, C. R., Joshi, P. H., Rohatgi, A. K., Khera, A., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117469 · Cited by 4
Periodontal diseases and carotid intima‐media thickness in Bangladesh
Wu, F., Chen, Y., Demmer, R. T., Parvez, F., Paul, R. R., Shaheen, I., Sarwar, G., Ahmed, A., Eunus, M., Ahsan, N., et al. (2016) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12597 · Cited by 4
“Both markers are positively associated with CVD risk (Ridker et al., 1998, Hansson et al., 2011).”
BackgroundManaging Cardiovascular Complications in Diabetes
Betteridge, J. D., & Nicholls, S. J. (2014) · Wiley eBooks · doi:10.1002/9781118337967 · Cited by 5
Raghavan, V. A., & Garber, A. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_7 · Cited by 4
Elevated Levels of Adhesion Proteins Are Associated With Low Ankle–Brachial Index
Berardi, C., Wassel, C. L., Decker, P. A., Larson, N. B., Kirsch, P. S., de Andrade, M., Tsai, M. Y., Pankow, J. S., Sale, M. M., Sicotte, H., et al. (2016) · Angiology · doi:10.1177/0003319716659178 · Cited by 4
The effect of weight change over a 2-year period on inflammatory status in postmenopausal women
Cronin, B. E., Allsopp, P. J., Slevin, M. M., Magee, P. J., McCaffrey, T. A., Livingstone, M. B. E., Strain, J., & McSorley, E. M. (2017) · European Journal of Clinical Nutrition · doi:10.1038/s41430-017-0014-9 · Cited by 4
“A similar percentage of weight or FM gain yields significant increases in the pro-inflammatory markers TNF-α, leptin and ICAM-1, the latter of which is associated with an increased risk of heart disease [32, 33].”
BackgroundICAM‐1 and MKL‐1 polymorphisms impose considerable impacts on coronary heart disease occurrence
Wu, C., & Huang, C. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15645 · Cited by 4
Chae, J. S., Kwak, J. H., Kim, M., Shin, K. H., Lee, S., Jeong, T., & Lee, J. H. (2014) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-014-1074-5 · Cited by 4
“ICAM-1, but not VCAM-1, has consistently been associated with the incidence of coronary artery disease in healthy populations [19–21].”
BackgroundMeasuring Soluble ICAM-1 in African Populations
Abdi, A. I., Muthui, M. K., Kiragu, E. W., & Bull, P. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108956 · Cited by 4
“Soluble levels of ICAM-1 (sICAM-1) in plasma have been associated with coronary heart disease and other vascular diseases [2].”
BackgroundTrøseid, M., Hjerkinn, E. M., Seljeflot, I., Klemsdal, T. O., Bergengen, L., Breivik, L., & Arnesen, H. (2006) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510500474462 · Cited by 4
“Increased levels of ICAM-1 are related to increased risk of future myocardial infarction [5] as well as to increased prevalence of coronary heart disease and carotid atherosclerosis [29].”
BackgroundOccult fungal infection is the underlying pathogenic cause of atherogenesis
Sastry, P. S. R. K. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.050 · Cited by 4
Pattan, V., Jehangir, W., Seth, S., Bhargava, B., & Maulik, S. K. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2178e · Cited by 4
“On the other hand, sVCAM-1 has failed to show such consistent association in studies [5, 26].”
BackgroundInfluentialThe Role of IL-33 in the Inflammation Process of Asthma and Atherosclerosis.
Fulgheri, G., & Malinowski, B. (2011) · PubMed Central · Cited by 4
Sacanella, E., Estruch, R., Nicolás, J., & Fernández-Solá, J. (2005) · Elsevier eBooks · doi:10.1016/b978-012564370-2/50088-x · Cited by 4
Microvascular Changes in the Diabetic Foot
Dinh, T., & Veves, A. (2006) · Humana Press eBooks · doi:10.1007/978-1-59745-075-1_7 · Cited by 4
HMG-CoA Reductase Inhibition in the Treatment of Atherosclerosis: Effects Beyond Lipid Lowering
März, W., & Br, W. (2002) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 4
Cell Adhesion Molecules in Cardiovascular Pathology – A Glance into the Future?
Goudev, A., Georgiev, D. B., Atar, D., Kehayov, I. R., & Kyurkchiev, S. (2001) · Heart Drug · doi:10.1159/000048964 · Cited by 4
Cohen, R. A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000137187.16206.79 · Cited by 4
Adiponectin. Spectator or Player?
Clark, W. M. (2005) · Stroke · doi:10.1161/01.str.0000177885.74606.d1 · Cited by 4
Koh, K. K., Yoon, B.-K., Merz, C. N. B., Sakuma, I., & Rebar, R. W. (2007) · Elsevier eBooks · doi:10.1016/b978-012369443-0/50042-9 · Cited by 4
ADAM proteases in cytokine biology: Modulators of immune signaling, inflammation and cancer
Khattab, H., Solujic, J., & Saad, M. I. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120137 · Cited by 4
Imani, M. M., Imani, A., Sadeghi, M., Brühl, A. B., & Brand, S. (2025) · Life · doi:10.3390/life15081278 · Cited by 3
Rogowicz‐Frontczak, A., Piłaciński, S., Araszkiewicz, A., Zozulińska‐Ziółkiewicz, D., Wykrętowicz, A., & Wierusz‐Wysocka, B. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12129 · Cited by 3
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Metadata
- Authors
- Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- R&D Systems (United States) (US)
- Corresponding author
- Ridker, Paul M
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 351
- Issue
- 9096
- Pages
- 88-92
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2138809584
- Cited by
- 1,229
- References
- 35
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 23 · 2018: 14 · 2017: 28 · 2016: 27 · 2015: 25 · 2014: 38 · 2013: 27 · 2012: 36
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- soluble intercellular adhesion molecule-1, sICAM-1, myocardial infarction, atherosclerosis, inflammation, endothelial cell adhesion, anti-adhesion therapy, cardiovascular risk, fibrinogen, homocysteine, tissue plasminogen activator, C-reactive protein, healthy men, Physicians' Health Study
- MeSH terms
- Antioxidants, Arteriosclerosis, Aspirin, Double-Blind Method, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Prospective Studies, Risk Factors, Multivariate Analysis, Case-Control Studies, Intercellular Adhesion Molecule-1, beta Carotene
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review